| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 181.638 | 208.315 | 280.183 | 365.163 | 436.981 | 561.030 | 633.298 | 750.678 | 793.265 | 815.469 |
| Total Income - EUR | 181.664 | 208.419 | 280.211 | 367.025 | 437.769 | 563.571 | 637.610 | 755.963 | 797.636 | 820.187 |
| Total Expenses - EUR | 188.763 | 214.128 | 293.348 | 352.969 | 435.561 | 542.036 | 599.871 | 723.299 | 784.123 | 808.318 |
| Gross Profit/Loss - EUR | -7.099 | -5.708 | -13.137 | 14.056 | 2.208 | 21.534 | 37.740 | 32.663 | 13.514 | 11.869 |
| Net Profit/Loss - EUR | -7.099 | -5.708 | -15.760 | 10.386 | -2.170 | 16.302 | 32.213 | 26.321 | 7.735 | 9.970 |
| Employees | 4 | 5 | 5 | 4 | 5 | 6 | 6 | 7 | 8 | 5 |
Check the financial reports for the company - Medafarm S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 11.337 | 6.437 | 2.847 | 3.760 | 3.203 | 1.928 | 1.645 | 28.067 | 23.392 | 17.490 |
| Current Assets | 39.569 | 32.321 | 54.306 | 63.335 | 66.305 | 97.364 | 110.652 | 127.491 | 152.172 | 155.797 |
| Inventories | 25.935 | 22.383 | 31.010 | 32.421 | 35.643 | 48.290 | 53.242 | 60.868 | 74.637 | 91.348 |
| Receivables | 12.273 | 4.408 | 19.011 | 27.727 | 26.584 | 39.560 | 48.737 | 57.943 | 66.649 | 42.493 |
| Cash | 1.362 | 5.530 | 4.286 | 3.187 | 4.077 | 9.514 | 8.673 | 8.680 | 10.886 | 21.956 |
| Shareholders Funds | -6.524 | -12.166 | -27.719 | -16.825 | -18.669 | -2.013 | 30.244 | 56.659 | 64.222 | 73.833 |
| Social Capital | 112 | 111 | 109 | 107 | 105 | 103 | 101 | 101 | 101 | 101 |
| Debts | 57.430 | 50.923 | 84.873 | 83.920 | 88.176 | 101.304 | 82.053 | 98.899 | 111.342 | 99.455 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Medafarm S.r.l.